TEVA vs. NVMI
TEVA (Teva Pharmaceutical Industries Limited) and NVMI (Nova Ltd) are both stocks. TEVA operates in Drug Manufacturers - Specialty & Generic (Healthcare), while NVMI operates in Semiconductor Equipment & Materials (Technology). Over the past 10 years, TEVA returned -4.15%/yr vs 46.09%/yr for NVMI. At a 0.17 correlation, their price movements are largely independent.
Performance
TEVA vs. NVMI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TEVA achieves a 6.57% return, which is significantly lower than NVMI's 54.68% return. Over the past 10 years, TEVA has underperformed NVMI with an annualized return of -4.15%, while NVMI has yielded a comparatively higher 46.09% annualized return.
TEVA
- 1D
- -2.72%
- 1M
- -6.91%
- YTD
- 6.57%
- 6M
- 17.40%
- 1Y
- 87.17%
- 3Y*
- 65.55%
- 5Y*
- 25.39%
- 10Y*
- -4.15%
NVMI
- 1D
- 6.77%
- 1M
- -2.53%
- YTD
- 54.68%
- 6M
- 52.63%
- 1Y
- 134.08%
- 3Y*
- 63.36%
- 5Y*
- 38.40%
- 10Y*
- 46.09%
TEVA vs. NVMI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries Limited | 6.57% | 41.61% | 111.11% | 14.47% | 13.86% | -16.99% | -1.53% | -36.45% | -18.63% | -46.18% |
NVMI Nova Ltd | 54.68% | 66.74% | 43.35% | 68.21% | -44.25% | 107.51% | 86.62% | 66.07% | -12.08% | 96.88% |
Correlation
The correlation between TEVA and NVMI is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Apr 12, 2000 | 0.17 |
The correlation between TEVA and NVMI shifts across timeframes, from 0.17 (all time) to 0.27 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
TEVA:
$39.21B
NVMI:
$17.49B
TEVA:
$1.34
NVMI:
$7.94
TEVA:
24.87
NVMI:
63.96
TEVA:
0.19
NVMI:
2.22
TEVA:
2.24
NVMI:
18.68
TEVA:
4.76
NVMI:
12.61
TEVA:
$17.35B
NVMI:
$902.53M
TEVA:
$9.03B
NVMI:
$518.59M
TEVA:
$3.05B
NVMI:
$293.89M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TEVA vs. NVMI — Risk / Return Rank
TEVA
NVMI
TEVA vs. NVMI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and Nova Ltd (NVMI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TEVA | NVMI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.30 | ||
| Sortino ratioReturn per unit of downside risk | +0.66 | ||
| Omega ratioGain probability vs. loss probability | 1.43 | 1.36 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 4.02 | 6.26 | -2.23 |
| Martin ratioReturn relative to average drawdown | 10.94 | 16.77 | -5.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TEVA | NVMI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.25 | 2.55 | -0.30 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.59 | 0.82 | -0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.09 | 1.07 | -1.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.21 | +0.11 |
Drawdowns
TEVA vs. NVMI - Drawdown Comparison
The maximum TEVA drawdown since its inception was -90.89%, smaller than the maximum NVMI drawdown of -98.22%. Use the drawdown chart below to compare losses from any high point for TEVA and NVMI.
Loading charts...
Drawdown Indicators
| TEVA | NVMI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.89% | -98.22% | +7.33% |
Max Drawdown (1Y)Largest decline over 1 year | -21.79% | -21.56% | -0.23% |
Max Drawdown (3Y)Largest decline over 3 years | -43.70% | -40.79% | -2.91% |
Max Drawdown (5Y)Largest decline over 5 years | -43.70% | -52.76% | +9.06% |
Max Drawdown (10Y)Largest decline over 10 years | -88.41% | -52.76% | -35.65% |
Current DrawdownCurrent decline from peak | -50.84% | -8.66% | -42.18% |
Average DrawdownAverage peak-to-trough decline | -32.00% | -51.79% | +19.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.00% | 8.03% | -0.03% |
Volatility
TEVA vs. NVMI - Volatility Comparison
The current volatility for Teva Pharmaceutical Industries Limited (TEVA) is 9.18%, while Nova Ltd (NVMI) has a volatility of 23.58%. This indicates that TEVA experiences smaller price fluctuations and is considered to be less risky than NVMI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TEVA | NVMI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.18% | 23.58% | -14.40% |
Volatility (6M)Calculated over the trailing 6-month period | 23.54% | 40.72% | -17.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.97% | 52.91% | -13.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.94% | 47.27% | -4.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 47.34% | 43.30% | +4.04% |
Dividends
TEVA vs. NVMI - Dividend Comparison
Neither TEVA nor NVMI has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVMI Nova Ltd | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.88% | 3.19% | 1.77% |
Financials
TEVA vs. NVMI - Financials Comparison
This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and Nova Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TEVA vs. NVMI - Profitability Comparison
TEVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 1.97B and revenue of 3.98B. Therefore, the gross margin over that period was 49.5%.
NVMI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nova Ltd reported a gross profit of 135.69M and revenue of 235.31M. Therefore, the gross margin over that period was 57.7%.
TEVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported an operating income of 652.00M and revenue of 3.98B, resulting in an operating margin of 16.4%.
NVMI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nova Ltd reported an operating income of 70.84M and revenue of 235.31M, resulting in an operating margin of 30.1%.
TEVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a net income of 369.00M and revenue of 3.98B, resulting in a net margin of 9.3%.
NVMI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nova Ltd reported a net income of 69.26M and revenue of 235.31M, resulting in a net margin of 29.4%.
Frequently Asked Questions
TEVA and NVMI have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVMI has higher volatility (23.58%) compared to TEVA (9.18%). In terms of maximum drawdown, TEVA dropped -90.89% vs NVMI's -98.22%.
NVMI currently has the higher Sharpe Ratio (2.55 vs 2.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TEVA and NVMI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer